Claude B. Sirlin
- Epidemiology top 0.01%
- Hepatology top 0.01%
- Radiology, Nuclear Medicine and Imaging top 0.02%
- Surgery top 0.2%
- Endocrinology, Diabetes and Metabolism top 0.1%
- Co-authors
- Rohit LoombaJulie K. HeimbachLewis R. RobertsGavin HamiltonLaura KulikJorge A. MarreroMichaël AbécassisAndrew X. Zhu
- Topics
- Liver Disease Diagnosis and Treatment (334 papers)Hepatocellular Carcinoma Treatment and Prognosis (201 papers)Liver Disease and Transplantation (117 papers)
- Journals
- Chemical ReviewsProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Claude B. Sirlin
471 papers receiving 41.1k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Epidemiology 24.6k
- Hepatology 20.6k
- Radiology, Nuclear Medicine and Imaging 9.1k
- Surgery 6.1k
- Endocrinology, Diabetes and Metabolism 4.7k
Countries citing papers authored by Claude B. Sirlin
This map shows the geographic impact of Claude B. Sirlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude B. Sirlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude B. Sirlin more than expected).
Fields of papers citing papers by Claude B. Sirlin
This network shows the impact of papers produced by Claude B. Sirlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude B. Sirlin. The network helps show where Claude B. Sirlin may publish in the future.
Co-authorship network of co-authors of Claude B. Sirlin
This figure shows the co-authorship network connecting the top 25 collaborators of Claude B. Sirlin. A scholar is included among the top collaborators of Claude B. Sirlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude B. Sirlin. Claude B. Sirlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 4 | |
| 7 | 19 | |
| 8 | 5 | |
| 9 | 23 | |
| 10 | 12 | |
| 11 | 20 | |
| 12 | 2 | |
| 13 | 11 | |
| 14 | 9 | |
| 15 | 65 | |
| 16 | 26 | |
| 17 | Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosisbreakdown → | 273 |
| 18 | 130 | |
| 19 | 175 | |
| 20 | 190 |
About Claude B. Sirlin
Claude B. Sirlin is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 485 papers that have together received 41.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (334 papers), Hepatocellular Carcinoma Treatment and Prognosis (201 papers) and Liver Disease and Transplantation (117 papers). The work is most often cited by research in Hepatology (20.6k citations), Epidemiology (24.6k citations) and Radiology, Nuclear Medicine and Imaging (9.1k citations). Claude B. Sirlin has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Rohit Loomba, Julie K. Heimbach, Lewis R. Roberts, Gavin Hamilton, Laura Kulik, Jorge A. Marrero, Michaël Abécassis, Andrew X. Zhu, Richard S. Finn and Michel Pfeffer. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.